tominersen

targets

all catalysts(0)

nothing on the calendar yet

News(3)

• Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
  Roche may have scrapped work on a T-cell engager being evaluated for lupus, but the company’s head of pharma told Fierce that still has a strategy for developing cell therapies for autoimmune disea…
  fiercebiotech · 25d ago
• Roche scraps two Ionis-partnered Huntington’s drugs
  The Swiss pharmaceutical giant told patient groups tominersen didn't delay disease progression in one trial, while a study of a second drug was scrapped because of a safety signal in animal testing.
  biopharma_dive · 1mo ago
• Roche ends work on tominersen after decade of trials, as well as early-stage Huntington’s asset
  After more than a decade of work and plenty of ups and downs, Roche has dropped its Huntington’s disease drug tominersen. The decision comes after tominersen did no better than placebo in a Phase 2…
  endpoints · 1mo ago